SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B1 - Prospectus [Rule 424(b)(1)]:
SEC Accession No. 0001193125-14-029666
Filing Date
2014-01-31
Accepted
2014-01-31 08:18:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B1 d652050d424b1.htm 424B1 1435357
2 GRAPHIC g652050g08r20.jpg GRAPHIC 97235
3 GRAPHIC g652050g88b19.jpg GRAPHIC 18996
  Complete submission text file 0001193125-14-029666.txt   1596827
Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B1 | Act: 33 | File No.: 333-193313 | Film No.: 14562801
SIC: 2834 Pharmaceutical Preparations